IP Library Granted Patent US 7,799,537
Granted Patent B2
US 7,799,537 · App. 11/720,338 · Granted Sep 21, 2010

Cholesterol measuring reagent containing a cholesterol esterase

Assignee: Otsuka Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,799,537
App. No.
11/720,338
Granted
Sep 21, 2010
Kind
B2
Abstract

There are provided a method and reagent for measuring cholesterol in remnant-like lipoprotein in a sample with high sensitivity by more simple operation. The method for measuring cholesterol in remnant-like lipoprotein uses a cholesterol esterase, in which the activity ratio of a lipoprotein lipase to a cholesterol esterase (lipoprotein lipase activity/cholesterol esterase activity) is from 12 to 7000 in a method for measuring cholesterol in the lipoprotein by measuring hydrogen peroxide or a reduced coenzyme obtained by allowing the cholesterol esterase and a cholesterol oxidase or a cholesterol dehydrogenase to act on a test sample containing a lipoprotein.

Claims (12)

1. A method for measuring cholesterol in remnant-like lipoprotein, comprising measuring cholesterol in the lipoprotein by measuring hydrogen peroxide or a reduced coenzyme obtained by allowing a cholesterol esterase and a cholesterol oxidase or a cholesterol dehydrogenase to act on a test sample containing a lipoprotein, wherein said cholesterol esterase has lipoprotein lipase activity and cholesterol esterase activity wherein the activity ratio of lipoprotein lipase activity to cholesterol esterase activity ranges from 12:1 to 7000:1.

2. The method according to claim 1 , wherein the activity ratio of lipoprotein lipase activity to cholesterol esterase activity ranges from 28:1 to 800:1.

3. The method according to claim 1 , wherein the cholesterol esterase is selected from a lipase from Chromobacterium viscosum wherein said activity ratio ranges 460:1 to 800:1 identified as LP, a lipase from an unknown microorganism wherein said activity ratio ranges from 5600:1 to 6900:1 identified as LPBP, a cholesterol esterase from Pseudomonas sp. wherein said activity ratio ranges from 13:1 to 16:1 identified as CEN, a cholesterol esterase from Pseudomonas sp. wherein said activity ratio ranges from 13:1 to 16:1 identified as CE, and a cholesterol esterase from Pseudomonas sp. wherein said activity ratio ranges from 28:1 to 35:1 identified as COE 311.

4. The method according to any one of claims 1 to 3 , further comprising pretreating the test sample with an anti-apoB-100 antibody and/or an anti-apoA-I antibody.

5. A measuring reagent for cholesterol in remnant-like lipoprotein, comprising:

a cholesterol esterase having lipoprotein lipase activity and cholesterol esterase activity wherein the activity ratio of lipoprotein lipase activity to cholesterol esterase activity ranges from 12:1 to 7000:1; and

a cholesterol oxidase or a cholesterol dehydrogenase.

6. The measuring reagent according to claim 5 , wherein the activity ratio of lipoprotein lipase activity to cholesterol esterase activity ranges from 28:1 to 800:1.

7. The reagent according to claim 5 , wherein the cholesterol esterase is selected from a lipase from Chromobacterium viscosum wherein said activity ratio ranges 460:1 to 800:1 identified as LP, a lipase from an unknown microorganism wherein said activity ratio ranges from 5600:1 to 6900:1 identified as LPBP, a cholesterol esterase from Pseudomonas sp. wherein said activity ratio ranges from 13:1 to 16:1 identified as CEN, a cholesterol esterase from Pseudomonas sp. wherein said activity ratio ranges from 13:1 to 16:1 identified as CE, and a cholesterol esterase from Pseudomonas sp. wherein said activity ratio ranges from 28:1 to 35:1 identified as COE 311.

8. A measuring reagent for cholesterol in remnant-like lipoprotein, comprising;

a first reagent comprising an anti-apoB-100 antibody and/or an anti-apoA-I antibody; and

a second reagent comprising the measuring reagent according to any one of claims 5 to 7 .

Assignments (4)
MERGER Recorded Aug 25, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 053598/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2011
From: OTSUKA PHARMACEUTICAL CO., LTD.
To: DENKA SEIKEN CO., LTD.
Reel/Frame 026469/0250 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2009
From: JIMRO CO., LTD.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 023712/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2008
From: NAKANO, TAKAMITU; NIIMI, MANABU; OGIHARA, FUMIKO
To: JIMRO CO., LTD.
Reel/Frame 021381/0507 →
Priority Claims (1)
JP 2004-344427 · Nov 29, 2004 · national
Continuity (1)
Related Publication 20080268461A1 · Oct 30, 2008